Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: A report from the BELSTRESS study

European Heart Journal

Volumn 26, Issue 24, 2005, Pages 2644-2649

  De Sutter, Johan ^a   De Bacquer, Dirk ^b   Cuypers, Sofie ^a   Delanghe, Joris ^b   De Buyzere, Mark ^a   Kornitzer, Marcel ^c   De Backer, Guy ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cardiac events; Cardiac risk factors; General population; Natriuretic peptide

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE; WORKER;

ADULT; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; EPIDEMIOLOGIC METHODS; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OCCUPATIONAL DISEASES; PEPTIDE FRAGMENTS; STRESS, PSYCHOLOGICAL; WORKPLACE;

EID: 28544450052     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi502     Document Type: Article

References (32)

1. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatini MS, McCabe CH, Hall C, Cannon CP, Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021.
2. Omland T, de Lemos JA, Morrow DA, Antman EM, Cannon CP, Hall C, Braunwald E. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. Am J Cardiol 2002;89:463-465.
3. Richards AM, Nicholls MG, Yanddle TG, Framptom C, Espiner EA, Turner TG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozieri G, Smyth DW. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-1929.
4. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal probrain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-1743.
5. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-675.
6. Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, Munzel T, Cambien F, Tiret L, Blankenberg S for the AtheroGene investigators. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2005;26:241-249.
7. Wallen T, Landahl S, Hedner T, Nakao K, Saito Y. Brain natriuretic peptide predicts mortality in the elderly. Heart 1997;77:264-267.
8. Ueda R, Yokouchi M, Suzuki T, Otomo E, Katagiri T. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med 2003;114:266-270.
9. McDonagh TA, Cunningham AD, Morrison CE, McMurray JJ, Ford I, Morton JJ, Dargie HJ. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001;86:21-26.
10. Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004;90:297-303.
11. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-663.
12. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005; 293:1609-1616.
13. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-328.
14. Boomsma F, Van der Meiracker AH. Plasma A-and B-type natriuretic peptides: physiology, methodology, and clinical use. Cardiovasc Res 2001;51:442-449.
15. Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptide during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond.) 1995;88:551-556.
16. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, Nielsen LB. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;17:1105-1107.
17. Bibbins-Domingo K, Ansari M, Schiller NB, Massie B, Whooley MA. B-type natriuretic peptide and ischemia in patients with stable coronary disease. Data from the Heart and Soul Study. Circulation 2003;108:2987-2992.
18. Coetsier P, De Backer G, De Corte W, Kornitzer M. Belgian job stress study (BELSTRESS): overview of the study model and research methods. Revue de Psychologie et de Psychométrie 1996;17:17-35.
19. Houtman I, Kornitzer M, De Smet P, De Backer G. Job stress, absenteeism and coronary heart disease European cooperative study. Design of a multicenter prospective study. Eur J Public Health 1999;9:52-57.
20. Kittel F, Leynen F, Stam M, Dramaix M, De Smet P, Kornitzer M, De Backer G. Job conditions and fibrinogen in 14226 Belgian workers: the Belstress study. Eur Heart J 2002;23:1841-1848.
21. De Bacquer D, Pelfrene E, Clays E, Mak R, Moreau M, De Smet P, Kornitzer M, De Backer G. Perceived job stress and incidence of coronary events: 3-year follow-up of the Belgian Job Stress Project cohort. Am J Epidemiol 2005;161:434-441.
22. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudicatio in field surveys. Bull World Health Organ 1962;27:645-658.
23. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiomyocyte hypertrophy. J Clin Invest 1995;96:1280-1287.
24. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, Nakao K, Redfield MM. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-994.
25. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with left ventricular dysfunction. Am Heart J 1998;135:825-832.
26. Schirmer H, Omland T. Circulating N-terminal pro-atrial natriuretic peptide is an independent predictor of left ventricular hypertrophy in the general population: the Tromso Study. Eur Heart J 1999;20:755-763 (erratum, Eur Heart J 1999;20:1439).
27. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y, Yamaguchi M, Hori R, Yasue H, Nakao K. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995;92:1558-1564.
28. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 2000;23:776-780.
29. Kook H, Itoh H, Choi BS, Sawada N, Doi K, Hwang TJ, Kim KK, Arai H, Baik YH, Nakao K. Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro. Am J Physiol Heart Circ Physiol 2003;284:H1388-H1397.
30. Brunner F, Wolkart G. Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature. Cardiovasc Res 2001;51:577-584.
31. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Veda M, Yoshikana J. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ Res 1997;81:585-590.
32. Herring N, Zaman JA, Paterson DJ. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway. Am J Physiol Heart Circ Physiol 2001;281:H2318-H2327.